Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Health, social, and economic consequences of rapid eye movement sleep behavior disorder: A Controlled National Study Evaluating Societal Effects

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Association between hospital-diagnosed sleep disorders and suicide: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Arousal characteristics in patients with Parkinson's disease and isolated rapid eye movement sleep behavior disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sleep-disordered breathing and cerebral small vessel disease-acute and 6 months after ischemic stroke

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Age estimation from sleep studies using deep learning predicts life expectancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The sequences of 150,119 genomes in the UK Biobank

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

STUDY OBJECTIVES: Parkinson's disease (PD) causes significant socioeconomic burdens. One of the strongest predictors of PD is rapid eye movement (REM) sleep behavior disorder (RBD; when there is no known other cause of RBD, referred to as idiopathic RBD [iRBD]), but there is no information about its factual welfare burden. We estimated the direct and indirect total costs of iRBD in a national sample of patients, based on a national register-based cohort study with matched controls.

METHODS: Using records from the Danish National Patient Registry, patient's diagnosis with RBD from 2006 to 2016 were identified. We excluded patients with a prior diagnosis of narcolepsy, PD, and other neurodegenerative diseases. We identified and compared randomly chosen controls matched for age, gender, geographic area, and civil status. Direct costs included frequencies of primary and secondary sector contacts and procedures, and medication. Indirect costs included the effect on labor supply. Social-transfer payments were included to illustrate the effect on national accounts.

RESULTS: A total of 246 iRBD patients and 982 matched controls were registered. iRBD patients had significantly higher rates of health-related contacts and of medication use, and higher socioeconomic costs than controls. The total additional direct net healthcare costs after the diagnosis (general practitioner services, hospital services, and medication) and indirect costs (loss of labor market income) was €13,088 for patients compared with controls. Patients already exhibited a negative social- and health-related status several years before the first diagnosis.

CONCLUSIONS: Diagnoses of iRBD have major socioeconomic consequences for patients, their partners, and society.

OriginalsprogEngelsk
Artikelnummerzsaa162
TidsskriftSleep
Vol/bind44
Udgave nummer2
ISSN1550-9109
DOI
StatusUdgivet - 12 feb. 2021

Bibliografisk note

© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

ID: 61827224